Catalent (CTLT) PT Raised to $137 at RBC Capital, 'COVID-Related Programs Continue to Drive FY21 Outlook Higher'
RBC Capital analyst Sean Dodge raised the price target on Catalent (NYSE: CTLT) to $137.00 (from $125.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
